Literature DB >> 21148358

National Institutes of Health. A government niche for translational medicine and drug development.

Jocelyn Kaiser.   

Abstract

Mesh：

Year:  2010        PMID： 21148358     DOI： 10.1126/science.330.6010.1462-b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Developing a multidisciplinary model of comparative effectiveness research within a clinical and translational science award.

Authors:  Paul R Marantz; A Hal Strelnick; Brian Currie; Rohit Bhalla; Arthur E Blank; Paul Meissner; Peter A Selwyn; Elizabeth A Walker; Daphne T Hsu; Harry Shamoon
Journal:  Acad Med       Date:  2011-06       Impact factor: 6.893

2.  Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

3.  New evidence on the allocation of NIH funds across diseases.

Authors:  Bhaven N Sampat; Kristin Buterbaugh; Marcel Perl
Journal:  Milbank Q       Date:  2013-03       Impact factor: 4.911

4.  Clinical pharmacology at the core of translational science.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.